Cargando…

Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis

BACKGROUND: Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease. The dysregulated immune system plays an important role in the pathogenesis of AS. Myeloid-derived suppressor cells (MDSCs) play a key immunoregulatory role in autoimmune arthritis. The aim of this study was to clari...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yu-feng, Zhuang, Kun-hai, Chen, Bin, Li, Pei-wu, Zhou, Xuan, Jiang, Hua, Zhong, Li-mei, Liu, Feng-bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091075/
https://www.ncbi.nlm.nih.gov/pubmed/30075733
http://dx.doi.org/10.1186/s13075-018-1654-4
_version_ 1783347326248550400
author Liu, Yu-feng
Zhuang, Kun-hai
Chen, Bin
Li, Pei-wu
Zhou, Xuan
Jiang, Hua
Zhong, Li-mei
Liu, Feng-bin
author_facet Liu, Yu-feng
Zhuang, Kun-hai
Chen, Bin
Li, Pei-wu
Zhou, Xuan
Jiang, Hua
Zhong, Li-mei
Liu, Feng-bin
author_sort Liu, Yu-feng
collection PubMed
description BACKGROUND: Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease. The dysregulated immune system plays an important role in the pathogenesis of AS. Myeloid-derived suppressor cells (MDSCs) play a key immunoregulatory role in autoimmune arthritis. The aim of this study was to clarify the underlying immunoregulatory mechanism of MDSCs in patients with AS. METHODS: Flow cytometry was used to analyze the phenotype of MDSCs among peripheral blood mononuclear cells (PBMCs) from 46 patients with AS and 46 healthy control subjects. The correlation between MDSC frequency and the disease index of patients with AS was evaluated. A T cell proliferation experiment was used to evaluate the immunosuppressive function of MDSCs. RESULTS: Polymorphonuclear (PMN) and monocytic (M)-MDSCs were significantly elevated in the PBMCs of patients with AS, when compared with levels in healthy controls. Additionally, M-MDSC levels correlated positively with the clinical index of AS, including the Bath ankylosing spondylitis disease activity index (BASDAI) score, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels. M-MDSCs derived from patients with AS suppressed T cell responses, and this effect was dependent on the induction of arginase-I. Furthermore, AS-derived M-MDSCs showed high levels of phosphorylated STAT3. Stattic, a STAT3-specific inhibitor, and STAT3-targeted siRNA abrogated the immunosuppressive function of M-MDSCs. Inhibition of STAT3 signaling also resulted in decreased arginase-I activity. CONCLUSIONS: STAT3/arginase-I signaling plays an important role in both the expansion and activation of M-MDSCs in patients with AS. This information may be beneficial in developing novel therapeutic strategies for preventing AS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13075-018-1654-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6091075
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60910752018-08-20 Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis Liu, Yu-feng Zhuang, Kun-hai Chen, Bin Li, Pei-wu Zhou, Xuan Jiang, Hua Zhong, Li-mei Liu, Feng-bin Arthritis Res Ther Research Article BACKGROUND: Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease. The dysregulated immune system plays an important role in the pathogenesis of AS. Myeloid-derived suppressor cells (MDSCs) play a key immunoregulatory role in autoimmune arthritis. The aim of this study was to clarify the underlying immunoregulatory mechanism of MDSCs in patients with AS. METHODS: Flow cytometry was used to analyze the phenotype of MDSCs among peripheral blood mononuclear cells (PBMCs) from 46 patients with AS and 46 healthy control subjects. The correlation between MDSC frequency and the disease index of patients with AS was evaluated. A T cell proliferation experiment was used to evaluate the immunosuppressive function of MDSCs. RESULTS: Polymorphonuclear (PMN) and monocytic (M)-MDSCs were significantly elevated in the PBMCs of patients with AS, when compared with levels in healthy controls. Additionally, M-MDSC levels correlated positively with the clinical index of AS, including the Bath ankylosing spondylitis disease activity index (BASDAI) score, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels. M-MDSCs derived from patients with AS suppressed T cell responses, and this effect was dependent on the induction of arginase-I. Furthermore, AS-derived M-MDSCs showed high levels of phosphorylated STAT3. Stattic, a STAT3-specific inhibitor, and STAT3-targeted siRNA abrogated the immunosuppressive function of M-MDSCs. Inhibition of STAT3 signaling also resulted in decreased arginase-I activity. CONCLUSIONS: STAT3/arginase-I signaling plays an important role in both the expansion and activation of M-MDSCs in patients with AS. This information may be beneficial in developing novel therapeutic strategies for preventing AS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13075-018-1654-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-03 2018 /pmc/articles/PMC6091075/ /pubmed/30075733 http://dx.doi.org/10.1186/s13075-018-1654-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Liu, Yu-feng
Zhuang, Kun-hai
Chen, Bin
Li, Pei-wu
Zhou, Xuan
Jiang, Hua
Zhong, Li-mei
Liu, Feng-bin
Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis
title Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis
title_full Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis
title_fullStr Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis
title_full_unstemmed Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis
title_short Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis
title_sort expansion and activation of monocytic-myeloid-derived suppressor cell via stat3/arginase-i signaling in patients with ankylosing spondylitis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091075/
https://www.ncbi.nlm.nih.gov/pubmed/30075733
http://dx.doi.org/10.1186/s13075-018-1654-4
work_keys_str_mv AT liuyufeng expansionandactivationofmonocyticmyeloidderivedsuppressorcellviastat3arginaseisignalinginpatientswithankylosingspondylitis
AT zhuangkunhai expansionandactivationofmonocyticmyeloidderivedsuppressorcellviastat3arginaseisignalinginpatientswithankylosingspondylitis
AT chenbin expansionandactivationofmonocyticmyeloidderivedsuppressorcellviastat3arginaseisignalinginpatientswithankylosingspondylitis
AT lipeiwu expansionandactivationofmonocyticmyeloidderivedsuppressorcellviastat3arginaseisignalinginpatientswithankylosingspondylitis
AT zhouxuan expansionandactivationofmonocyticmyeloidderivedsuppressorcellviastat3arginaseisignalinginpatientswithankylosingspondylitis
AT jianghua expansionandactivationofmonocyticmyeloidderivedsuppressorcellviastat3arginaseisignalinginpatientswithankylosingspondylitis
AT zhonglimei expansionandactivationofmonocyticmyeloidderivedsuppressorcellviastat3arginaseisignalinginpatientswithankylosingspondylitis
AT liufengbin expansionandactivationofmonocyticmyeloidderivedsuppressorcellviastat3arginaseisignalinginpatientswithankylosingspondylitis